Madrigal Pharmaceuticals Inc
MDGL
Market Cap$7.16B
Close$
$-0.92
100.3% downside
Current Fair Value
100.3% downsideOvervalued by 100.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.16 Billion |
|---|---|
| Enterprise Value | $6.93 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-19.99 |
| Beta | -0.47 |
| Outstanding Shares | 21,745,929 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -13.76 |
|---|---|
| PEG | -165.18 |
| Price to Sales | 164.07 |
| Price to Book Ratio | 9.38 |
| Enterprise Value to Revenue | 111.38 |
| Enterprise Value to EBIT | -12.88 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Madrigal Pharmaceuticals Inc
CEO: Rebecca Taub